GCF Levels of IL-1Beta, MIP-1 Alfa and G-CSF in Gingivitis and Stage I-II-III-IV Periodontitis Patients
Study Details
Study Description
Brief Summary
Periodontal diseases are chronic diseases that occur as a result of a violation of the balance between microbial dental plaque and the host response. Gingivitis is a disease characterized by inflammation of the gums that occurs in one or more areas without loss of attachments.1 in periodontitis, an inflammatory event that begins in the gum along with gingivitis spreads to the periodontal ligament, alveolar bone and soft tissues that support the tooth, causing the destruction of these structures.2 Cytokines are low molecular weight proteins that participate in the initial and active stages of inflammation and immunity. In periodontal disease pathogenesis, cytokine response has been reported to play a very critical role in determining disease progression.3 IL-1beta, MIP-1alfa and G-CSF are key cytokines in chronic inflammatory diseases and have the potential to initiate bone loss and tissue destruction seen in periodontal disease.4the purpose of this study; it is to determine the degree of inflammation and periodontal destruction by determining the levels of IL-1beta, MIP-1alfa, G-CSF cytokines in the gum groove fluid of periodontal healthy and diseased individuals.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Plaque index (PI), gingival index (GI), presence of bleeding on probing (BOP), pocket depth (PD) and clinical attachment level (CAL) were used After clinical evaluation, individuals were divided into 6 groups Healthy control groups, gingivitis groups, Stage I groups, Stage II groups, Stage III groups and Stage IV groups GCF samples were collected after clinical periodontal measurement. GCF was obtained using strips of filter paper Kolmogorov-Smirnov and Shapiro Wilk's tests used
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
periodontal disease group Gingivitis: BOP score of 10% or greater and PD≤3mm with no attachment or radiographic bone loss. SI Periodontitis: interdental AL of 1-2 mm, PD≤4 mm and no tooth loss SII Periodontitis: interdental AL of 3-4 mm, PD≤5 mm and no tooth loss SIII Periodontitis: interdental AL ≥5 mm, PD≥6 mm SIV Periodontitis: interdental AL ≥5 mm teeth, radiographic bone lose extending to middle or apical third of the root, |
|
periodontal healthy group consisted of individuals with clinically healthy gingiva |
Outcome Measures
Primary Outcome Measures
- Measurement of IL-1Beta, G-CSF, MIP-1alfa levels in GCF [GCF samples were collected in the morning hours 24-48 hours after clinical periodontal measurement. GCF was obtained using strips of filter paper† from the buccal part of an interproximal region.]
Measurement of GCF samples
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Clinical diagnosis of periodontal diseases
-
Individuals must have 16 permanent teeth in their mouth
Exclusion Criteria:
-
Diabetes
-
İmmunological diseases
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Usak | Uşak | Turkey | 64200 |
Sponsors and Collaborators
- Uşak University
Investigators
- Principal Investigator: ahu dikilitaş, University of Usak
- Study Chair: fatih karaaslan, University of Usak
- Study Chair: umut yiğit, University of Usak
- Study Chair: esra özge aydın, University of Usak
- Study Director: Abdullah seçkin ertuğrul, University of Usak
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- UsakU6